Home ›
NPI 1225554843
NPI deactivated
1225554843
1225554843 was paid $411K by Medicaid between Jul 2018 and Aug 2024, across 20 billing codes. Its largest line is 87798, Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism — 51% of everything it billed.
33Billing provider info1225554843
33aNPI1225554843
33bProvider type—
28Total paid$411K
24GClaims35,059
24DCodes billed20
24AFirst – last monthJul 2018 – Aug 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 538 | $5K | |
| 2019 | 198 | $654.04 | |
| 2020 | 796 | $10K | |
| 2021 | 440 | $24K | |
| 2022 | 4,325 | $169K | |
| 2023 | 15,087 | $118K | |
| 2024incomplete | 13,675 | $85K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 51% | 5,391 | 3,679 | $210K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 12% | 1,713 | 1,695 | $51K |
| 87507 | 5.4% | 753 | 751 | $22K | |
| 87481 | 4.6% | 2,753 | 2,619 | $19K | |
| 87631 | 3.8% | 528 | 455 | $16K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.8% | 4,168 | 2,964 | $15K |
| 87640 | 3.6% | 4,250 | 2,956 | $15K | |
| 87486 | 2.1% | 2,723 | 2,587 | $9K | |
| 87581 | 2.1% | 2,683 | 2,549 | $9K | |
| 87541 | 2.1% | 2,575 | 2,452 | $9K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.7% | 1,121 | 1,113 | $7K |
| 87634 | 1.6% | 1,227 | 1,216 | $7K |
8 more codes
| 87529 | 1.6% | 1,142 | $6K | |
| 87498 | <1% | 1,144 | $4K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 412 | $3K |
| 87551 | <1% | 1,068 | $3K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 130 | $3K |
| 87561 | <1% | 1,130 | $2K | |
| 81226 | <1% | 73 | $2K | |
| 81225 | <1% | 75 | $999.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.